Incyte (INCY) Tops Q2 EPS by 28c, raises FY23 Guidance
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $124.40 -1.85%
EPS Growth %: -225.2%
Financial Fact:
Research and development: 143.18M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -225.2%
Financial Fact:
Research and development: 143.18M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q2 EPS of $0.99, $0.28 better than the analyst estimate of $0.71. Revenue for the quarter came in at $954.61 million versus the consensus estimate of $911.68 million.
Guidance:
Raising the bottom end of full year guidance to a new range of $2.58 - $2.63 billion for FY 2023
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
- JPMorgan Downgrades AVI Limited (AVI:SJ) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
